Cure My Disease

Don't miss your cure!

 Log in / Sign up

Wireless body sensors tested on 13,000 patients to prevent hospital deaths

NCT ID NCT06644599

Disease control Sponsor: King Abdullah International Medical Research Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a wireless monitoring system that tracks heart rate, oxygen levels, breathing, and blood pressure can help prevent deaths and serious complications in hospital patients. Over 13,000 adults admitted to general wards will be monitored continuously. The goal is to see if early detection of deterioration reduces deaths, cardiac arrests, and the need for intensive care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
wireless monitoring system (device)
What this could lead to
If successful, this could become a standard way to continuously monitor hospital patients, potentially preventing many deaths and emergencies.
What could go wrong
This is a large trial, but the device itself does not treat disease—it only alerts staff. Benefits depend on how quickly staff respond, and results may vary across hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 13,160 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

14 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Ward level Inpatient wards, defined as wards used to manage adult inpatients. Patient level 1. Aged 14 years or older 2. Checked in as inpatient status to one of the study wards Exclusion Criteria: Ward level 1. Cardiology, pediatric, obstetric wards 2. ICUs and emergency departments 3. Operating rooms 4. Outpatient clinics 5. Daycare wards, endoscopy, outpatient procedure areas, hemodialysis units Patient level No commitment for full life support at the time of arrival to the study ward (designated as Do-Not-Resuscitate status)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Inpatient facililty diagnoses are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Inpatient facililty diagnoses

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia

    RECRUITING

    Riyadh, Riyadh Region, Saudi Arabia

More trials for these conditions

Other studies related to the condition(s) this trial covers.